Since most drugs exert their therapeutic effects by targeting proteins, we combined drug-gene interaction analyses to screen disulfiram and eugenol as potentially effective drugs for BC, whereas GSR and PMAIP1 were found to be associated with a variety of drugs and may be important targets for the treatment of BC (Figure 9A). The gene discussed is GSR; the disease is breast cancer.